HIKMA FDA Approval ANDA 203662

ANDA 203662

HIKMA

FDA Drug Application

Application #203662

Application Sponsors

ANDA 203662HIKMA

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTIONEQ 1MG BASE/ML0NOREPINEPHRINE BITARTRATENOREPINEPHRINE BITARTRATE

FDA Submissions

UNKNOWN; ORIG1AP2018-11-07STANDARD
LABELING; LabelingSUPPL3AP2021-02-26STANDARD
LABELING; LabelingSUPPL4AP2021-02-26STANDARD

Submissions Property Types

ORIG1Null15
SUPPL3Null15
SUPPL4Null7

TE Codes

001PrescriptionAP

CDER Filings

HIKMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 203662
            [companyName] => HIKMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"NOREPINEPHRINE BITARTRATE","activeIngredients":"NOREPINEPHRINE BITARTRATE","strength":"EQ 1MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/07\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-11-07
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.